The Government and the Pharmacy association recognise that valuable health outcomes can be achieved through the release of proof based professional pharmacy programs and services. To this end the Fourth Agreement will offer $500 million in funding for professional pharmacy programs and services. This represents an increase from $400 million allocated under the Third Agreement.The Fourth Agreement will continue to fund programs that were funded under the ThirdAgreement, such as Home Medicines Review, and it will fund new programs aimed at improving community health outcomes, such as in the areas of asthma, diabetes and communicable diseases.For further information on Professional Pharmacy Programs and Services refer to Part 5 of the Fourth Agreement.